These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25172122)
1. Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population - results from the PolSenior substudy. Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J Metabolism; 2014 Nov; 63(11):1409-18. PubMed ID: 25172122 [TBL] [Abstract][Full Text] [Related]
2. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling. Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122 [TBL] [Abstract][Full Text] [Related]
3. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy. Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462 [TBL] [Abstract][Full Text] [Related]
4. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration is not related to kidney function in elderly subjects. Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bozentowicz-Wikarek M; Brzozowska A; Mossakowska M; Skalska A; Wiecek A; Chudek J Clin Chem Lab Med; 2015 Apr; 53(5):793-9. PubMed ID: 25274953 [TBL] [Abstract][Full Text] [Related]
5. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Oki K; Yamane K; Kamei N; Nojima H; Kohno N Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078 [TBL] [Abstract][Full Text] [Related]
6. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration in elderly subjects with metabolic syndrome. Kocełak P; Olszanecka-Glinianowicz M; Owczarek AJ; Krupa W; Obirek P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Skalska A; Więcek A; Chudek J Pol Arch Med Wewn; 2015; 125(6):402-13. PubMed ID: 25924024 [TBL] [Abstract][Full Text] [Related]
7. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Chang YC; Chang TJ; Lee WJ; Chuang LM Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775 [TBL] [Abstract][Full Text] [Related]
8. Elevated visfatin levels in obese children are related to proinflammatory factors. Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785 [TBL] [Abstract][Full Text] [Related]
9. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans. Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460 [TBL] [Abstract][Full Text] [Related]
10. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes. Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women. Unlütürk U; Harmanci A; Yildiz BO; Bayraktar M Clin Endocrinol (Oxf); 2010 Apr; 72(4):469-74. PubMed ID: 19650786 [TBL] [Abstract][Full Text] [Related]
12. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models. Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis. de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645 [TBL] [Abstract][Full Text] [Related]
14. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy. Alghasham AA; Barakat YA Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224 [TBL] [Abstract][Full Text] [Related]
15. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly. Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029 [TBL] [Abstract][Full Text] [Related]
16. The effect of sodium restricted diet on plasma visfatin levels in hypertensive patients with visceral obesity. Rotkegel S; Chudek J; Spiechowicz-Zaton U; Ficek R; Adamczak M; Wiecek A Kidney Blood Press Res; 2013; 37(2-3):124-31. PubMed ID: 23615125 [TBL] [Abstract][Full Text] [Related]
17. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism. Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942 [TBL] [Abstract][Full Text] [Related]
18. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. Goktas Z; Owens S; Boylan M; Syn D; Shen CL; Reed DB; San Francisco S; Wang S Mediators Inflamm; 2013; 2013():861496. PubMed ID: 24367155 [TBL] [Abstract][Full Text] [Related]
19. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus]. Zhang XJ; Wang Z; Li HH; Yu L; Gao S Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671 [TBL] [Abstract][Full Text] [Related]
20. Plasma visfatin level in women with polycystic ovary syndrome. Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]